These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 15574752)

  • 21. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
    Schmidt M; Patterson M; Farrell E; Münsterberg A
    Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
    Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
    Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative evaluation of beta-catenin and plakoglobin signaling activity.
    Williams BO; Barish GD; Klymkowsky MW; Varmus HE
    Oncogene; 2000 Nov; 19(50):5720-8. PubMed ID: 11126358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC; Kim K
    Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin.
    Kawasoe T; Furukawa Y; Daigo Y; Nishiwaki T; Ishiguro H; Fujita M; Satoh S; Miwa N; Nagasawa Y; Miyoshi Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Jul; 60(13):3354-8. PubMed ID: 10910037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
    Chen RH; McCormick F
    Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
    Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
    Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
    Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation.
    Spychala J; Kitajewski J
    Exp Cell Res; 2004 Jun; 296(2):99-108. PubMed ID: 15149841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A common human skin tumour is caused by activating mutations in beta-catenin.
    Chan EF; Gat U; McNiff JM; Fuchs E
    Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
    Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
    Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells.
    Sekiya T; Adachi S; Kohu K; Yamada T; Higuchi O; Furukawa Y; Nakamura Y; Nakamura T; Tashiro K; Kuhara S; Ohwada S; Akiyama T
    J Biol Chem; 2004 Feb; 279(8):6840-6. PubMed ID: 14660579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.
    Wielenga VJ; Smits R; Korinek V; Smit L; Kielman M; Fodde R; Clevers H; Pals ST
    Am J Pathol; 1999 Feb; 154(2):515-23. PubMed ID: 10027409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.
    Kolligs FT; Nieman MT; Winer I; Hu G; Van Mater D; Feng Y; Smith IM; Wu R; Zhai Y; Cho KR; Fearon ER
    Cancer Cell; 2002 Mar; 1(2):145-55. PubMed ID: 12086873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter.
    Vadlamudi U; Espinoza HM; Ganga M; Martin DM; Liu X; Engelhardt JF; Amendt BA
    J Cell Sci; 2005 Mar; 118(Pt 6):1129-37. PubMed ID: 15728254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells.
    Jansson EA; Are A; Greicius G; Kuo IC; Kelly D; Arulampalam V; Pettersson S
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1460-5. PubMed ID: 15665104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkuhn is perturbed by stimulation of Lef-1/beta-catenin signaling.
    Wong MH; Huelsken J; Birchmeier W; Gordon JI
    J Biol Chem; 2002 May; 277(18):15843-50. PubMed ID: 11854293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.
    Kolligs FT; Hu G; Dang CV; Fearon ER
    Mol Cell Biol; 1999 Aug; 19(8):5696-706. PubMed ID: 10409758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.